Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1182–1190. doi: 10.1161/ATVBAHA.118.311894

Table 4.

Hazard ratios with 95% confidence intervals of top three PLA2G2A variants influencing sPLA2-IIA mass levels and incident CVD

PLA2G2A variants
(minor allele)		 Homozygous for
non-effect allele		 Intermediate genotype Homozygous for
effect allele		 HR (95% CI) per minor
allele		 P Value for
additive model
rs11573156 (G) 1 1.06 (0.80-1.40) 1.36 (0.79-2.34) 1.11 (0.89-1.38) 0.34
rs2307246 (T) 1 1.12 (0.90-1.39) 0.32
rs4744 (T) 1 1.11 (0.89-1.38) 0.37

HRs (95% CI) are adjusted for age, sex, randomization treatment assignment, region and measures of subpopulation stratification HR denotes hazard ratio; and CI, confidence interval.